Opyl Health Care
Biotech Healthcare Medical Pharmaceuticals

$0.022 0.004 (22.22%)

High $0.02	Low $0.02	Trades 1	Turnover $275	Volume 12,500
30 June 2023 at 3:35pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code OPL	Name Opyl Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Health Care Equipment & Services	GIC Industry Health Care Technology	GIC Sub Industry Health Care Technology
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 296,081,984	Shares Floated 90,089,868	Held by Insiders 56.706%	Held by Institutions 4.06%

Directors & Officers

Name & Education	Position
Mr. Saurabh Jain	Interim CEO & Executive Chairman
Mr. Mark Ziirsen	Chief Financial Officer
Mr. Damon Rasheed	CTO & Executive Director
Bernice Averion	Head of Marketing & Communications
Mr. Shane Lewis	Vice President of Sales & Partnerships
Mr. Matt Hallam	Chief Revenue Officer
Mr. Jonathan Hart B.Com., L.L.B.	Company Secretary

OPL Historic Dividends

Date	Amount
We found no dividends on record for OPL.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.02	1,396,936	0.00 (14.29%)
12-Sep	$0.03	285,180	+0.00 (3.70%)
11-Sep	$0.03	330,666	0.00 (10.00%)
05-Sep	$0.03	54,747	0.00 (6.25%)
04-Sep	$0.03	1,471,898	+0.00 (6.67%)
03-Sep	$0.03	2,782,061	+0.01 (25.00%)
29-Aug	$0.02	1,354,348	+0.00 (9.09%)
28-Aug	$0.02	200,000	0.00 (4.35%)
22-Aug	$0.02	0	0.00 (0.00%)
21-Aug	$0.02	0	+0.00 (4.55%)
15-Aug	$0.02	0	0.00 (0.00%)
14-Aug	$0.02	23,000	+0.00 (4.76%)
07-Aug	$0.02	1,735,170	0.00 (8.70%)
31-Jul	$0.02	299,893	+0.00 (9.52%)
30-Jul	$0.02	182,000	0.00 (4.55%)
7 up, 6 down, and 2 flat days

Market Cap (19-Sep) $6,513,803	EBITDA -	PE 0.00	Book Value $0.00
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.01	Profit Margin N/A
Operating Margin -1523.76%	ROA 296.24%	ROE 248.28%	Revenue (FY) $196,095
Revenue per Share $0.00	Gross Profit (FY) $-1,277,733	Q' YOY Revenue Growth 82.7%	Q' YOY Earnings Growth -

Opyl Health Care
Biotech Healthcare Medical Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2024)

Directors & Officers

OPL Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Opyl Health Care Biotech Healthcare Medical Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2024)

Directors & Officers

OPL Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Opyl Health Care
Biotech Healthcare Medical Pharmaceuticals